| Structure |
Chemical Name |
CAS |
MF |
 |
Canagliflozin Impurity 60 |
|
|
 |
Canagliflozin Impurity 65 |
|
|
 |
Rosuvastatin Impurity 75 |
|
|
 |
Selexipag Impurity 6 |
|
|
 |
Cabozantinib impurity N |
|
|
 |
Barcitinib impurity-09 |
1187594-16-6 |
C14H13N7 |
 |
Rotigotine Impurity 6 |
|
|
 |
Olprinone Impurity 7 |
2236020-10-1 |
C9H10N2 |
 |
Cilastatin Impurity 2 |
|
|
 |
Cilastatin Impurity 7 |
|
|
 |
Dabrafenib Impurity 1 |
1907654-22-1 |
C24H21F3N4O3S2 |
 |
Trelagliptin Impurity SJ |
2087874-94-8 |
C40H42F2N10O6 |
 |
AztreonaM IMpurity C |
|
|
 |
Pramipexole Related Impurity 3 |
2166216-34-6 |
C10H17N3OS |
 |
Lincomycin sulfoxide Impurity 5 |
|
|
 |
Sulpiride Impurity 4 |
|
|
 |
Tacrolimus Impurity E |
|
|
 |
Bumetanide iMpurity E |
|
|
 |
2-クロロトリチルアルコール |
66774-02-5 |
C19H15ClO |
 |
開環アゼトレオナム |
87500-74-1 |
C13H19N5O9S2 |
 |
Traxipide impurity |
|
|
![6-(benzyloxy)-8-(2-broMoacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one](/CAS/GIF/926319-53-1.gif) |
6-(benzyloxy)-8-(2-broMoacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one |
926319-53-1 |
C17H14BrNO4 |
![ethyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-N-pentanoyl-L-valinate](/CAS/20150408/GIF/1111177-30-0.gif) |
ethyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-N-pentanoyl-L-valinate |
1111177-30-0 |
C26H33N5O3 |
 |
Regorafenib Impurity 2 |
|
|
 |
Vonoprazan Impurity 5 |
|
|
 |
Bendamustine |
1219709-86-0 |
C14H18ClN3O2 |
 |
Dapagliflozin Impurity E |
|
|
 |
Febuxostat Impurity 14 |
1335202-60-2 |
C15H16N2OS |
 |
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one |
1367369-77-4 |
C12H15N5O3 |
 |
Carfilzomib Impurity B |
|
|
 |
Ornidazole Impurity 1 |
1100750-18-2 |
|
 |
Ornidazole Impurity |
1100750-18-2 |
|
 |
4-(3-nitrophenyl)-3-Morpholinone |
845729-43-3 |
C10H10N2O4 |
 |
1,3-bis(2-chloroethyl)benzimidazolin-2-one |
55470-74-1 |
C11H12Cl2N2O |
 |
Nintedanib Impurity A (Intedanib Impurity A ) |
|
|
 |
Tigecycline Impurity 6 |
|
|
 |
Febuxostat Bromo Impurity |
144060-40-2 |
C15H16BrNO3S |
 |
Meptazinol Impurity |
1314003-47-8 |
C23H28N2O4 |
![(7S,8R)-3-[2-(tert-butylamino)acetamido]-7-[[4-carbamoyl-2-(dimethylamino)-3,5,6-trihydroxyphenyl]methyl]-6-carboxy-5,8-dihydroxy-N,N-dimethyl-4-oxo-7,8-dihydronaphthalen-1(4H)-iminium](/CAS/20180703/GIF/CB53371328.gif) |
(7S,8R)-3-[2-(tert-butylamino)acetamido]-7-[[4-carbamoyl-2-(dimethylamino)-3,5,6-trihydroxyphenyl]methyl]-6-carboxy-5,8-dihydroxy-N,N-dimethyl-4-oxo-7,8-dihydronaphthalen-1(4H)-iminium |
|
C29H38N5O10+ |
 |
1-((2R,3R)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-((methyl(3-((2-(methylamino)acetoxy)methyl)pyridin-1-oxide-2-yl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium |
|
|
![2-Piperidinecarboxylic acid, 1-formyl-, (1S,2R,3S,6R,7E,10S,12S)-3-hydroxy-1-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-12-methoxy-2,8,10-trimethyl-5-oxo-6-(2-propen-1-yl)-12-[(2R,3S,5R)-tetrahydro-3-methoxy-5-methyl-6-oxo-2H-pyra](/CAS/20210111/GIF/143210-33-7.gif) |
2-Piperidinecarboxylic acid, 1-formyl-, (1S,2R,3S,6R,7E,10S,12S)-3-hydroxy-1-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-12-methoxy-2,8,10-trimethyl-5-oxo-6-(2-propen-1-yl)-12-[(2R,3S,5R)-tetrahydro-3-methoxy-5-methyl-6-oxo-2H-pyra |
143210-33-7 |
C43H69NO11 |
![IMp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethyl- thiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin)](/) |
IMp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethyl- thiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin) |
|
|
 |
methyl (Z)-3-(((4-(2-(4-(2-((4-((((Z)-6-(methoxymethyl)-2-oxoindolin-3-ylidene)(phenyl)methyl)amino)phenyl)(methyl)amino)-2-oxoethyl)piperazin-1-yl)-N-methylacetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
2097505-01-4 |
C56H54N8O7 |
 |
Ropivacaine-cycle |
1945965-95-6 |
C17H24N2O |
 |
4-(5-methyl-4-phenylisoxazol-3-yl)benzenesulfonamide |
181696-12-8 |
C16H14N2O3S |
 |
Bupivacaine Impurity |
2125995-27-7 |
C18H28N2O.ClH |
 |
Brexpiprazole Impurity |
2059954-32-2 |
C17H21Cl2NO2 |
 |
BDJS-SH 2 |
36585-31-6 |
C12H18N2O2 |
 |
Ampicillin EP Impurity M |
114977-84-3 |
C48H57N9O12S3 |
 |
Blonanserin impurity D |
|
|
 |
Captopril impurity 3 |
|
|
 |
Peramivir Impurity 48 |
|
|
 |
Tolvaptan dehydroxylated impurity |
|
|
![8,11-Dioxa-3,5-diazadodecanoic acid, 12-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-10-(hydroxymethyl)-2,6-bis(1-methylethyl)-7-oxo-, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, (2S,6S)-](/CAS/20210305/GIF/1654737-35-5.gif) |
8,11-Dioxa-3,5-diazadodecanoic acid, 12-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-10-(hydroxymethyl)-2,6-bis(1-methylethyl)-7-oxo-, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, (2S,6S)- |
1654737-35-5 |
C29H44N12O10 |
 |
プレドニカルベート関連化合物A (1,2-DIHYDROPREDNI1,2-ジヒドロプレドニカルベート |
671225-26-6 |
C27H38O8 |
 |
Methyl 2-Acetyl-3-(3-nitrophenyl)-5-oxo-hexanoate |
2469555-30-2 |
C15H17NO6 |
 |
Clonidine Related Compound A (1-acetyl-2-(2,6-dichlorophenylimino)imidazolidine) |
54707-71-0 |
C11H11Cl2N3O |
 |
Mupirocin iMpurity 2 |
|
C26H44O9 |
 |
Ceftriaxone Sodium impurity 5 |
|
|
 |
Sugammadex sodium Org48302 Impurity |
|
|
 |
176761-00-5 |
176761-00-5 |
C17H15FN2O5 |
 |
Pramipexole Impurity W |
|
|
 |
Oseltamivir Impurity 26 |
241465-24-7 |
|
 |
Moxifloxacin Impurity 5 |
|
|
 |
Moxifloxacin Impurity 24 |
|
|
 |
Fosaprepitant Impurity 1 |
|
|
 |
Ticagrelor Impurity 1 |
|
|
 |
Ezetimibe Impurity 36 |
|
|
 |
Pitavastatin Impurity 2 |
|
|
 |
Fudosteine Impurity 2 |
|
|
 |
Sugammadex Impurity 18 |
|
|
 |
Mirabegron Impurity 21 |
|
|
 |
Clopidogrel Impurity 12 |
|
C15H14ClNO2S |
 |
Oseltamivir Impurity 25 |
|
|
 |
Ritonavir EP Impurity P |
|
|
 |
Tacrolimus Impurity 4 |
686773-61-5 |
C44H69NO12 |
 |
methyl 3-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)-3- oxopropanoate hydrochloride |
|
C16H24ClNO5 |
 |
Vitamin E Impurity 3 |
1560705-69-2 |
C29H50O2 |
![(trans)-phenyl3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro-[1,1'-biphenyl]-3-yl)piperidine-1-carboxylate](/CAS/20200331/GIF/CB45442085.gif) |
(trans)-phenyl3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro-[1,1'-biphenyl]-3-yl)piperidine-1-carboxylate |
|
C32H28FNO5 |
 |
Cefraprazole impurity |
|
|
 |
3β-トシルオキシ-5α-アンドロスタン-17-オン |
10429-07-9 |
C26H36O4S |
 |
Cabozantinib Impurity 48 |
202916-99-2 |
C17H15NO3 |
 |
Landiolol impurity R |
|
|
 |
6-Oxo-Palonosetron |
848074-10-2 |
C19H22N2O2 |
 |
Teneligliptin Impurity 8 |
|
|
![(trans)-4-(4'-fluoro-[1,1'-biphenyl]-3-yl)-1-methylpiperidin-3-yl) methanol](/) |
(trans)-4-(4'-fluoro-[1,1'-biphenyl]-3-yl)-1-methylpiperidin-3-yl) methanol |
|
|
![2,4(1H,3H)-Pyrimidinedione, 3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-](/CAS/20200331/GIF/2354391-45-8.gif) |
2,4(1H,3H)-Pyrimidinedione, 3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl- |
2354391-45-8 |
C13H10F4N2O2 |
 |
Cyclopropane, nitroso- |
28017-92-7 |
C3H5NO |
 |
Hyoscine Butylbromide EP Impurity D |
|
|
 |
Carbetocin Impurity 1 |
|
|
 |
Carboprost Trometamol Impurity A |
|
|
 |
Procaine Impurity 2 |
|
C13H20N2O2 |
 |
Triphenylmethanol (Zidovudine impurity) |
|
C19H16O |
 |
Tofacitinib Impurity 110 |
|
|
![methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate](/CAS/20200611/GIF/383910-25-6.gif) |
methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate |
383910-25-6 |
C18H30N2O5 |
 |
sodium (((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy) methyl)oxidophosphoryl)-L-alaninate |
382140-24-1 |
C12H19N6O5P |
 |
Zopiclone Impurity 13 |
|
|
 |
1-メチルインドリン-2,3-ジオン |
2058-74-4 |
C9H7NO2 |
 |
Olanzapine impurity Q |
|
C17H20N4S |
 |
Palbociclib Impurity 32 |
|
|